|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM020974647 |
| 003 |
DE-627 |
| 005 |
20250125103355.0 |
| 007 |
tu |
| 008 |
231221s1990 xx ||||| 00| ||jpn c |
| 028 |
5 |
2 |
|a pubmed25n0070.xml
|
| 035 |
|
|
|a (DE-627)NLM020974647
|
| 035 |
|
|
|a (NLM)2116083
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a jpn
|
| 100 |
1 |
|
|a Naito, K
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Prophylactic effect of UFT on the recurrence of bladder cancer
|
| 264 |
|
1 |
|c 1990
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 05.09.1990
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a To evaluate the effect of UFT, a mixture of ftorafur and uracil in a ratio of 1:4, in preventing postoperative recurrence of bladder cancer, we performed a randomized controlled study with a non-medication group as control. UFT was given orally 400 mg a day for 6 months. Of 111 patients, 56 were given UFT and 55 were followed up without any medication. The non-recurrence rate in the group treated with UFT was 62.8% after 1 year and 36.3% after 2 years of follow up, and that of the control group was 45.7% and 39.5%, respectively. The rate of non-recurrence in the UFT group was significantly higher (p less than 0.05) than that of the control group during the period of follow up for 2 years. The incidence of side effects was 6.8% in UFT patients. These results indicate the clinical usefulness of prophylactic administration of UFT for bladder cancer patients
|
| 650 |
|
4 |
|a Clinical Trial
|
| 650 |
|
4 |
|a English Abstract
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Multicenter Study
|
| 650 |
|
4 |
|a Randomized Controlled Trial
|
| 650 |
|
7 |
|a Tegafur
|2 NLM
|
| 650 |
|
7 |
|a 1548R74NSZ
|2 NLM
|
| 650 |
|
7 |
|a Uracil
|2 NLM
|
| 650 |
|
7 |
|a 56HH86ZVCT
|2 NLM
|
| 700 |
1 |
|
|a Hisazumi, H
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Saka, A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Nakamura, T
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kanda, S
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Mikawa, I
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ejiri, S
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Miyagi, T
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Katsumi, T
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kitagawa, K
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 36(1990), 4 vom: 04. Apr., Seite 487-94
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnas
|
| 773 |
1 |
8 |
|g volume:36
|g year:1990
|g number:4
|g day:04
|g month:04
|g pages:487-94
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 36
|j 1990
|e 4
|b 04
|c 04
|h 487-94
|